U.S Department of Health and Human Services U.S Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Home » Resources » Substance-Exposed Infants

Substance-Exposed Infants

Each year, an estimated 400,000–440,000 infants (10–11% of all births) are affected by prenatal alcohol or illicit drug exposure, as described in the analysis in this section. Prenatal exposure to alcohol, tobacco, and illicit drugs has the potential to cause a wide spectrum of physical, emotional, and developmental problems for these infants. The harm caused to the child can be significant and long-lasting, especially if the exposure is not detected and the effects are not treated as soon as possible.

To fully address substance exposed infant issues, they must be handled in an intensely collaborative setting, since no single agency has the resources, the information base, or the lead role to address the full range of needs of all substance-exposed or substance-affected newborns and their families. If concern for these children is to continue past birth, the number of families who may need services increases to several million; these are the families of preschoolers who were prenatally exposed, many of whom may also be affected by continuing substance use disorders in their families. These increases in the scope and complexity of States’ interagency networking are important aspects of the context for State substance exposed infant policy and its implementation.

Statistics and Factsheets

  • Substance Use among Women During Pregnancy and Following Childbirth
    Office of Applied Studies. (2008).
    Examines past month use of alcohol, cigarettes, and marijuana among pregnant and parenting women aged 18 to 44 to shed light on how rapidly use of these substances resumes after childbirth.
  • Alcohol Use among Pregnant Women and Recent Mothers: 2002 to 2007
    Office of Applied Studies. (September 11, 2008).
    This report concentrates on alcohol use among women of childbearing age (i.e., those aged 15 to 44). Comparisons are made between the alcohol use of pregnant women, recent mothers, and women who were not pregnant and not recent mothers.
  • Prenatal Substance Exposure (April 2008) (PDF 991 KB)
    National Abandoned Infants Assistance Resource Center
    A factsheet about the contributing factors of substance use among pregnant women, its consequences, and possible paths to address the problem

Policy and Practice Resources

  • Substance-Exposed Infants:  State Responses to the Problem (PDF 1,150 KB)
    Young, N. K., Gardner, S., Otero, C., Dennis, K., Chang, R., Earle, K., & Amatetti, S
    Substance Abuse and Mental Health Services Administration, 2009
    This study assessed State policy from the broadest perspective: prevention, intervention, identification, and treatment of prenatal substance exposure, including immediate and ongoing services for the infant, the mother, and the family.
  • Guttmacher Institute Substance Abuse during Pregnancy, State Policies in Brief (PDF 196 KB)
    Reviews all states' policies concerning prenatal exposure and how it is treated by the child welfare system.
  • Substance-Exposed Infants: Current Issues and Responses (PDF 475 KB)
    American Professional Society on the Abuse of Children Advisor 19(4), 2007
    Provides a brief review of prevalence estimates, a summary of state policies and programs to assist families of substance-exposed infants, and suggestions of needed interventions in both policy and direct practice.
  • Collaborative Approaches to Identifying and Serving Substance Exposed Newborns: Lessons Learned from Four Demonstration Projects In this webcast , hosted by the National AIA Resource Center, representatives from four federally funded demonstration projects share their experiences developing policies and procedures to meet the federal Child Abuse Prevention and Treatment Act (CAPTA) mandates related to substance exposed newborns (SEN). Specifically, the presenters discuss challenges they have encountered in multidisciplinary collaboration, and strategies they have employed to overcome those challenges.
  • Substance Exposed Infants: Noteworthy Policies & Practices (2006) (PDF 146 KB)
    National Abandoned Infants Assistance Resource Center
    This issue brief outlines the relevant policy issues and challenges facing states and presents differing perspectives in terms of both policy and practice that affect pregnant substance users and their infants. It also highlights a few approaches taken by states to address these issues.
  • SAMHSA Fetal Alcohol Spectrum Disorders Center for Excellence
    Website has a wealth of resources for persons interested in fetal alcohol spectrum disorders, including a FASD resource database with over 5,000 entries. Their site also has fact sheets, special reports, an events calendar, and more.
  • Baby Steps: Caring for Babies with Prenatal Substance Exposure (December 2003) (PDF 1.25 MB)
    Ministry of Children and Family Development, British Columbia
    Information in this guide focuses on the daily care of babies aged birth to 6 months of age who have been exposed to substances in the womb. This caregiver guide is intended to be a hands-on resource for parents and caregivers of babies who have been prenatally exposed to alcohol and other drugs.
  • Improving Treatment for Drug Exposed Infants
    Examines guidelines and standards of care in monitoring and evaluating programs that treat drug-exposed infants. Treatment Improvement Protocol (TIP) Series 5.

State and Local Examples

Additional Resources

  • The Listening Heart
    Presents the daily challenges of families who struggle with the consequences of Fetal Alcohol Syndrome. It approaches the issue from the perspective of medical experts, adoptive parents, and affected children, combining parents’ insight with medical information.
  • National Abandoned Infants Assistance Resource Center
    The Center’s mission is to enhance the quality of social and health services delivered to children who are abandoned or at-risk of abandonment due to the presence of drugs and/or HIV in the family.

Related Presentations